Farhat Gul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Farhat Gul has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Banzeer Ahsan Abbasi
Department of Botany, Rawalpindi Women University, Rawalpindi, Pakistan
2 shared publications - Javed Iqbal
Department of Botany, Bacha Khan University, Charsadda 24420, Khyber Pakhtunkhwa, Pakistan
2 shared publications - Mohamed Abdelraouf El‑Sheikh
Botany & Microbiology Department, College of Science, King Saud University, Riyadh, Saudi Arabia
1 shared publication - Riaz Ahmad
College of Life Sciences, Shaanxi Normal University, Xian, China
1 shared publication - Safia Hameed
Department of Biotechnology Quaid‐I‐Azam University Islamabad Pakistan
1 shared publication - Sheeza Bashir
Department of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan
1 shared publication
Latest Publications
- Open Access
- 20 April 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (4) , 1069
Biogenic Synthesis of Multifunctional Silver Oxide Nanoparticles (Ag2ONPs) Using Parieteria alsinaefolia Delile Aqueous Extract and Assessment of Their Diverse Biological Applications
Green nanotechnology has made the synthesis of nanoparticles a possible approach. Nanotechnology has a significant impact on several scientific domains and has diverse applications in different commercial areas. The current study aimed to develop a novel and green approach for the biosynthesis of silver oxide nanoparticles (Ag2ONPs) utilizing Parieteria alsinaefolia leaves extract as a reducing, stabilizing and capping agent. The change in color of the reaction mixture from light brown to reddish black determines the synthesis of Ag2ONPs. Further, different techniques were used to confirm the synthesis of Ag2ONPs, including UV-Visible spectroscopy, Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscope (SEM), Energy-dispersive X-ray spectroscopy (EDX), zeta potential and dynamic light scattering (DLS) analyses. The Scherrer equation determined a mean crystallite size of ~22.23 nm for Ag2ONPs. Additionally, different in vitro biological activities have been investigated and determined significant therapeutic potentials. Radical scavenging DPPH assay (79.4%), reducing power assay (62.68 ± 1.77%) and total antioxidant capacity (87.5 ± 4.8%) were evaluated to assess the antioxidative potential of Ag2ONPs. The disc diffusion method was adopted to evaluate the antibacterial and antifungal potentials of Ag2ONPs using different concentrations (125–1000 μg/mL). Moreover, the brine shrimp cytotoxicity assay was investigated and the LC50 value was calculated as 2.21 μg/mL. The biocompatibility assay using red blood cells (2ONPs. Alpha-amylase inhibition assay was performed and reported 66% inhibition. In conclusion, currently synthesized Ag2ONPs have exhibited strong biological potential and proved as an attractive eco-friendly candidate. In the future, this preliminary research work will be a helpful source and will open new avenues in diverse fields, including the pharmaceutical, biomedical and pharmacological sectors.
- 20 April 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (4) , 1069
Open AccessBiogenic Synthesis of Multifunctional Silver Oxide Nanoparticles (Ag2ONPs) Using Parieteria alsinaefolia Delile Aqueous Extract and Assessment of Their Diverse Biological Applications
Green nanotechnology has made the synthesis of nanoparticles a possible approach. Nanotechnology has a significant impact on several scientific domains and has diverse applications in different commercial areas. The current study aimed to develop a novel and green approach for the biosynthesis of silver oxide nanoparticles (Ag2ONPs) utilizing Parieteria alsinaefolia leaves extract as a reducing, stabilizing and capping agent. The change in color of the reaction mixture from light brown to reddish black determines the synthesis of Ag2ONPs. Further, different techniques were used to confirm the synthesis of Ag2ONPs, including UV-Visible spectroscopy, Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscope (SEM), Energy-dispersive X-ray spectroscopy (EDX), zeta potential and dynamic light scattering (DLS) analyses. The Scherrer equation determined a mean crystallite size of ~22.23 nm for Ag2ONPs. Additionally, different in vitro biological activities have been investigated and determined significant therapeutic potentials. Radical scavenging DPPH assay (79.4%), reducing power assay (62.68 ± 1.77%) and total antioxidant capacity (87.5 ± 4.8%) were evaluated to assess the antioxidative potential of Ag2ONPs. The disc diffusion method was adopted to evaluate the antibacterial and antifungal potentials of Ag2ONPs using different concentrations (125–1000 μg/mL). Moreover, the brine shrimp cytotoxicity assay was investigated and the LC50 value was calculated as 2.21 μg/mL. The biocompatibility assay using red blood cells (2ONPs. Alpha-amylase inhibition assay was performed and reported 66% inhibition. In conclusion, currently synthesized Ag2ONPs have exhibited strong biological potential and proved as an attractive eco-friendly candidate. In the future, this preliminary research work will be a helpful source and will open new avenues in diverse fields, including the pharmaceutical, biomedical and pharmacological sectors.
- 18 March 2019
- Published by Springer Nature in Pharmacological Reports
- Vol. 71 (4) , 644-652
Potential phytochemicals in the prevention and treatment of esophagus cancer: A green therapeutic approach
Globally, esophagus cancer (EC) is one of the most frequently reported malignancies and leading cause of deaths. Currently, different treatment methods are available like chemotherapy, radiation therapy, surgery or their combination. These treatment strategies are not enough and are often associated with adverse side effects. The alternate treatment option like phytochemicals have come up with ease of bioavailability and cost-effectiveness. Due to general acceptance, lower side effects, safety and pleiotropic effect, phytochemicals can be used as an adjuvant treatment for alleviating side effects associated with chemotherapy and radiotherapy. Phytochemicals perform multiple functions; release cytochrome-c, loss mitochondrial membrane potential, down-regulate expression of anti-apoptotic proteins, up-regulate pro-apoptotic proteins, activate caspases, p53, inhibit Akt/mTOR signaling pathway, phosphorylate NF-kB, STAT3 and PI3 K. The knowledge compiled here encompasses anti-EC phytochemicals, their occurrence, bioavailability therapeutic effects and mechanism of action by targeting several genes and signaling pathways. Overall, the clinical data compiled on phytochemicals against EC is not sufficient and need future research to provide additional insights for developing potential anticancer drugs in pharma industries.
- 18 March 2019
- Published by Springer Nature in Pharmacological Reports
- Vol. 71 (4) , 644-652
Potential phytochemicals in the prevention and treatment of esophagus cancer: A green therapeutic approach
Globally, esophagus cancer (EC) is one of the most frequently reported malignancies and leading cause of deaths. Currently, different treatment methods are available like chemotherapy, radiation therapy, surgery or their combination. These treatment strategies are not enough and are often associated with adverse side effects. The alternate treatment option like phytochemicals have come up with ease of bioavailability and cost-effectiveness. Due to general acceptance, lower side effects, safety and pleiotropic effect, phytochemicals can be used as an adjuvant treatment for alleviating side effects associated with chemotherapy and radiotherapy. Phytochemicals perform multiple functions; release cytochrome-c, loss mitochondrial membrane potential, down-regulate expression of anti-apoptotic proteins, up-regulate pro-apoptotic proteins, activate caspases, p53, inhibit Akt/mTOR signaling pathway, phosphorylate NF-kB, STAT3 and PI3 K. The knowledge compiled here encompasses anti-EC phytochemicals, their occurrence, bioavailability therapeutic effects and mechanism of action by targeting several genes and signaling pathways. Overall, the clinical data compiled on phytochemicals against EC is not sufficient and need future research to provide additional insights for developing potential anticancer drugs in pharma industries.